BioSpace News Archive

atai Life Sciences N.V., a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced that it will participate in a fireside chat and one-on-one investor meetings at the Canaccord Genuity Growth Conference, to be held virtually from August 10-12, 2021.

InflaRx will present at the BTIG Virtual Biotechnology Conference on August 10.

Ocugen today reported second quarter 2021 financial results along with a general business update.

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.

Apnimed today announced that the Company’s management team will participate in the Canaccord Genuity Virtual 41 st Annual Growth Conference, held August 12-13, 2021.

Mayo Clinic and Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) co-hosted the Gastroesophageal Cancer Educational Symposium Clinic on Saturday, July 31, 2021 , in Rochester, Minnesota .

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Increase in number of promotional activities carried out by key players has played a major role in the growth of the brain health supplements market.

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.

Synedgen, a biotechnology company using glycopolymer chemistry to develop therapeutics that enhance and control signaling in the innate immune system, today announced the initiation of a randomized controlled trial (RCT) to test the safety and effectiveness of SynePure™ Wound Cleanser (SynePure) in combination with Catasyn™ Advanced Technology Hydrogel (Catasyn) for the treatment of superficial partial-thickness burn wounds.